MicroRNAs: Important Regulators of Induced Pluripotent Stem Cell Generation and Differentiation

Induced pluripotent stem (iPS) cells can differentiate into nearly all types of cells. In contrast to embryonic stem cells, iPS cells are not subject to immune rejection because they are derived from a patient's own cells without ethical concerns. These cells can be used in regenerative medical...

Full description

Saved in:
Bibliographic Details
Published in:Stem cell reviews and reports Vol. 14; no. 1; pp. 71 - 81
Main Authors: Zeng, Zhao-Lin, Lin, Xiao-Long, Tan, Li-Lan, Liu, Ya-Mi, Qu, Kai, Wang, Zuo
Format: Journal Article
Language:English
Published: United States Springer Nature B.V 01.02.2018
Subjects:
Animals
Cell Differentiation - genetics
Cell Differentiation - physiology
Drug development
Drug discovery
Embryo cells
Ethics
Humans
Induced Pluripotent Stem Cells - cytology
Induced Pluripotent Stem Cells - metabolism
MicroRNAs
MicroRNAs - genetics
MicroRNAs - physiology
miRNA
Pluripotency
Stem cells
Therapeutic applications
Transcription factors
Induced pluripotent stem cell
Generation
MicroRNA
Differentiation
ISSN:2629-3269, 2629-3277, 2629-3277
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Induced pluripotent stem (iPS) cells can differentiate into nearly all types of cells. In contrast to embryonic stem cells, iPS cells are not subject to immune rejection because they are derived from a patient's own cells without ethical concerns. These cells can be used in regenerative medical techniques, stem cell therapy, disease modelling and drug discovery investigations. However, this application faces many challenges, such as low efficiency, slow generation time, partially reprogrammed colonies and tumourigenicity. Numerous techniques have been formulated in the past decade to improve reprogramming efficiency and safety, including the use of different transcription factors, small molecule compounds and non-coding RNAs. Recently, microRNAs (miRNAs) were found to promote the generation and differentiation of iPS cells. The miRNAs can more effectively and safely generate iPS cells than transcription factors. This process ultimately leads to the development of iPSC-based therapeutics for future clinical applications. In this comprehensive review, we summarise advances in research and the application of iPS cells, as well as recent progress in the use of miRNAs for iPS cell generation and differentiation. We examine possible clinical applications, especially in cardiology.
AbstractList Induced pluripotent stem (iPS) cells can differentiate into nearly all types of cells. In contrast to embryonic stem cells, iPS cells are not subject to immune rejection because they are derived from a patient's own cells without ethical concerns. These cells can be used in regenerative medical techniques, stem cell therapy, disease modelling and drug discovery investigations. However, this application faces many challenges, such as low efficiency, slow generation time, partially reprogrammed colonies and tumourigenicity. Numerous techniques have been formulated in the past decade to improve reprogramming efficiency and safety, including the use of different transcription factors, small molecule compounds and non-coding RNAs. Recently, microRNAs (miRNAs) were found to promote the generation and differentiation of iPS cells. The miRNAs can more effectively and safely generate iPS cells than transcription factors. This process ultimately leads to the development of iPSC-based therapeutics for future clinical applications. In this comprehensive review, we summarise advances in research and the application of iPS cells, as well as recent progress in the use of miRNAs for iPS cell generation and differentiation. We examine possible clinical applications, especially in cardiology.
Induced pluripotent stem (iPS) cells can differentiate into nearly all types of cells. In contrast to embryonic stem cells, iPS cells are not subject to immune rejection because they are derived from a patient's own cells without ethical concerns. These cells can be used in regenerative medical techniques, stem cell therapy, disease modelling and drug discovery investigations. However, this application faces many challenges, such as low efficiency, slow generation time, partially reprogrammed colonies and tumourigenicity. Numerous techniques have been formulated in the past decade to improve reprogramming efficiency and safety, including the use of different transcription factors, small molecule compounds and non-coding RNAs. Recently, microRNAs (miRNAs) were found to promote the generation and differentiation of iPS cells. The miRNAs can more effectively and safely generate iPS cells than transcription factors. This process ultimately leads to the development of iPSC-based therapeutics for future clinical applications. In this comprehensive review, we summarise advances in research and the application of iPS cells, as well as recent progress in the use of miRNAs for iPS cell generation and differentiation. We examine possible clinical applications, especially in cardiology.Induced pluripotent stem (iPS) cells can differentiate into nearly all types of cells. In contrast to embryonic stem cells, iPS cells are not subject to immune rejection because they are derived from a patient's own cells without ethical concerns. These cells can be used in regenerative medical techniques, stem cell therapy, disease modelling and drug discovery investigations. However, this application faces many challenges, such as low efficiency, slow generation time, partially reprogrammed colonies and tumourigenicity. Numerous techniques have been formulated in the past decade to improve reprogramming efficiency and safety, including the use of different transcription factors, small molecule compounds and non-coding RNAs. Recently, microRNAs (miRNAs) were found to promote the generation and differentiation of iPS cells. The miRNAs can more effectively and safely generate iPS cells than transcription factors. This process ultimately leads to the development of iPSC-based therapeutics for future clinical applications. In this comprehensive review, we summarise advances in research and the application of iPS cells, as well as recent progress in the use of miRNAs for iPS cell generation and differentiation. We examine possible clinical applications, especially in cardiology.
Author Tan, Li-Lan
Qu, Kai
Lin, Xiao-Long
Zeng, Zhao-Lin
Liu, Ya-Mi
Wang, Zuo
Author_xml – sequence: 1
  givenname: Zhao-Lin
  surname: Zeng
  fullname: Zeng, Zhao-Lin
  organization: Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, University of South China, Hengyang, Hunan, 421001, China
– sequence: 2
  givenname: Xiao-Long
  surname: Lin
  fullname: Lin, Xiao-Long
  organization: Department of Pathology, Huizhou Third People's Hospital, Guangzhou Medical University, Huizhou, Guangdong, 516002, China
– sequence: 3
  givenname: Li-Lan
  surname: Tan
  fullname: Tan, Li-Lan
  organization: Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, University of South China, Hengyang, Hunan, 421001, China
– sequence: 4
  givenname: Ya-Mi
  surname: Liu
  fullname: Liu, Ya-Mi
  organization: Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, University of South China, Hengyang, Hunan, 421001, China
– sequence: 5
  givenname: Kai
  surname: Qu
  fullname: Qu, Kai
  organization: Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, University of South China, Hengyang, Hunan, 421001, China
– sequence: 6
  givenname: Zuo
  orcidid: 0000-0002-0612-1933
  surname: Wang
  fullname: Wang, Zuo
  email: smt121101@163.com
  organization: Institute of Cardiovascular Research, Key Laboratory for Atherosclerology of Hunan Province, University of South China, Hengyang, Hunan, 421001, China. smt121101@163.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29143183$$D View this record in MEDLINE/PubMed
BookMark eNpdkD1PwzAQhi1URKH0B7AgSywsAX_ETsxWFSiVyocKzJHjnFGqxC52MvDvCVAYmO50eu7u0XuERs47QOiEkgtKSHYZKSNUJIRmicpykcg9dMgkUwlnWTb666Uao2mMG0II4yQdVg7QmCmacprzQ1Tc1yb49cMsXuFlu_Wh067Da3jrG935ELG3eOmq3kCFn5o-1FvfwUA8d9DiOTQNXoCDoLvaO6xdha9rayEMSP09O0b7VjcRprs6Qa-3Ny_zu2T1uFjOZ6vEpDzvEllanevcSClKYUsKvOSKGKrTUkhODOSDP0BqTaqNLZkFpbmtRJmTVFaZ5RN0_nN3G_x7D7Er2jqawU878H0sqJKCScqUGNCzf-jG98ENdl9UypWgw88JOt1RfdlCVWxD3erwUfxGxz8B_D9zvA
CitedBy_id crossref_primary_10_1186_s13287_020_01842_0
crossref_primary_10_1007_s11626_018_0272_4
crossref_primary_10_1016_j_phrs_2022_106475
crossref_primary_10_3390_ijms20061420
crossref_primary_10_1186_s13287_024_03883_1
crossref_primary_10_1155_2021_4229721
crossref_primary_10_1002_cbin_11314
crossref_primary_10_1089_cell_2019_0035
crossref_primary_10_1186_s12967_019_02137_6
crossref_primary_10_1016_j_biosystems_2021_104453
crossref_primary_10_1111_jcmm_16861
crossref_primary_10_3390_ijms21010362
crossref_primary_10_1002_jcp_27509
crossref_primary_10_1007_s10238_022_00854_9
crossref_primary_10_3892_etm_2019_8148
crossref_primary_10_1002_cbf_3552
crossref_primary_10_3390_cancers14112585
crossref_primary_10_3389_fgene_2022_899831
crossref_primary_10_1186_s13287_019_1154_8
crossref_primary_10_1002_stem_3272
crossref_primary_10_1016_j_crmeth_2023_100570
crossref_primary_10_3390_ijms19051276
crossref_primary_10_1002_advs_202104296
crossref_primary_10_1007_s12015_018_9859_0
crossref_primary_10_1097_CM9_0000000000001772
crossref_primary_10_3390_cells10123540
crossref_primary_10_3390_ijms21093242
crossref_primary_10_1007_s12015_019_09931_1
crossref_primary_10_1111_cpr_12563
crossref_primary_10_1016_j_copbio_2021_07_021
ContentType Journal Article
Copyright Stem Cell Reviews and Reports is a copyright of Springer, (2017). All Rights Reserved.
Copyright_xml – notice: Stem Cell Reviews and Reports is a copyright of Springer, (2017). All Rights Reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TK
7X7
7XB
88E
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
DOI 10.1007/s12015-017-9785-6
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Biotechnology and BioEngineering Abstracts
Proquest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest Central Student
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2629-3277
EndPage 81
ExternalDocumentID 29143183
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: the Natural Science Foundation of China
  grantid: 81600342
– fundername: the Natural Science Foundation of China
  grantid: 81070221
GroupedDBID -EM
06C
0R~
203
2JN
2JY
406
53G
7X7
88E
8AO
8FI
8FJ
AACDK
AAHNG
AAJBT
AANZL
AASML
AATNV
AAUYE
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABJNI
ABJOX
ABKCH
ABMQK
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABUWG
ABWNU
ACAOD
ACDTI
ACHSB
ACHXU
ACMDZ
ACOKC
ACPIV
ACZOJ
ADKNI
ADTPH
ADURQ
ADYFF
AEBTG
AEFQL
AEGAL
AEMSY
AEOHA
AESKC
AEVLU
AFBBN
AFKRA
AFLOW
AFQWF
AGMZJ
AGQEE
AGQMX
AGRTI
AIAKS
AIGIU
AILAN
AJZVZ
ALMA_UNASSIGNED_HOLDINGS
AMXSW
AMYLF
AOCGG
BBNVY
BENPR
BGNMA
BHPHI
BSONS
CGR
CSCUP
CUY
CVF
DDRTE
DNIVK
DPUIP
EBLON
ECM
EIF
EMOBN
FERAY
FIGPU
FNLPD
FYUFA
GGCAI
GNWQR
GQ7
HCIFZ
HMCUK
IKXTQ
IWAJR
J-C
JBSCW
JZLTJ
LLZTM
M1P
M4Y
M7P
NPM
NPVJJ
NQJWS
NU0
PSQYO
PT4
Q2X
QOR
R89
ROL
RSV
SDH
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SV3
UKHRP
UOJIU
UTJUX
ZMTXR
3V.
7T5
7TK
7XB
8FD
8FE
8FH
8FK
AAPKM
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
AYFIA
AZQEC
CCPQU
DWQXO
FR3
GNUQQ
H94
K9.
LK8
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
PUEGO
ID FETCH-LOGICAL-c438t-6bfa8a8c665b5fb1e3b390c1a4b5630ce8000ee4fc4acfb2fe9a3fd5b8046d7f3
IEDL.DBID M7P
ISICitedReferencesCount 36
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000424277300006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2629-3269
2629-3277
IngestDate Fri Sep 05 11:28:33 EDT 2025
Tue Nov 04 22:07:47 EST 2025
Wed Feb 19 02:32:25 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Induced pluripotent stem cell
Generation
MicroRNA
Differentiation
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c438t-6bfa8a8c665b5fb1e3b390c1a4b5630ce8000ee4fc4acfb2fe9a3fd5b8046d7f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Literature Review-3
ObjectType-Review-3
content type line 23
ORCID 0000-0002-0612-1933
PMID 29143183
PQID 1964395156
PQPubID 326299
PageCount 11
ParticipantIDs proquest_miscellaneous_1965261295
proquest_journals_1964395156
pubmed_primary_29143183
PublicationCentury 2000
PublicationDate 2018-02-01
PublicationDateYYYYMMDD 2018-02-01
PublicationDate_xml – month: 02
  year: 2018
  text: 2018-02-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle Stem cell reviews and reports
PublicationTitleAlternate Stem Cell Rev Rep
PublicationYear 2018
Publisher Springer Nature B.V
Publisher_xml – name: Springer Nature B.V
SSID ssj0002304015
Score 2.3368063
SecondaryResourceType review_article
Snippet Induced pluripotent stem (iPS) cells can differentiate into nearly all types of cells. In contrast to embryonic stem cells, iPS cells are not subject to immune...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 71
SubjectTerms Animals
Cell Differentiation - genetics
Cell Differentiation - physiology
Drug development
Drug discovery
Embryo cells
Ethics
Humans
Induced Pluripotent Stem Cells - cytology
Induced Pluripotent Stem Cells - metabolism
MicroRNAs
MicroRNAs - genetics
MicroRNAs - physiology
miRNA
Pluripotency
Stem cells
Therapeutic applications
Transcription factors
Title MicroRNAs: Important Regulators of Induced Pluripotent Stem Cell Generation and Differentiation
URI https://www.ncbi.nlm.nih.gov/pubmed/29143183
https://www.proquest.com/docview/1964395156
https://www.proquest.com/docview/1965261295
Volume 14
WOSCitedRecordID wos000424277300006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAVX
  databaseName: Springer Journals
  customDbUrl:
  eissn: 2629-3277
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002304015
  issn: 2629-3269
  databaseCode: RSV
  dateStart: 20050301
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7xKFIvQMujy2NlJK4WIbGdmAviKSq1q9Xy0N4i27ElpCWhm2wl_j1jJwsnuHDxxZEVecbjz-PP8wEcWsWER6q40mJLmUkiqj3XVSZaO-woRFBrePiTDgbZeCyHXcKt7miV85gYAnVRGZ8jPwqFoxAOcHH6_I961Sh_u9pJaCzCsq-SEAfq3vAtx-ITnlEQMYhFLCkiFTm_2Ayv53Dz88y1lOJRilPxMcgMm8312ld_cx1WO5hJzlq_-AELtvwJK63w5MsG5H89D280OKtPyO-nAMHLhoxaXfpqWpPKES_qYWxBhpMZBpYKsXVDbhv7RC7sZELactXeqkSVBbnsdFaa1tKbcH99dXdxQzupBWpYkjVUaKcylRkhuOZOH9tEJzIyx4ppX0DMWMSVkbXMGaaM07GzUiWu4DrD83WRumQLlsqqtL-AeAVrzuOIMVmwIk2VwIHRVRBo8shw1oO9-czl3Xqp8_dp68HBWzd6ur--UKWtZuEb7gueSd6D7dY6-XNbkiOPJeI-jE47nw--C9_R5lnLut6DpWY6s_vwzfxvHutpHxbTcRrarA_L51eD4agfHArb0e3DK1Sk0Ns
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1NT9wwEB1RaAWXfpcupa0rtUerIbGdBKmqEBSxYlkhSqu9pbZjI6QloZssFX-qv7Ezzoae6I1Dz44sOX4ev2eP5wG8d1ooYqq40mLHhU0ibijXNU-M8dhQquDW8H2UjsfZZJIfL8Hv_i0MpVX2MTEE6rK2dEb-MRSOQjog1efLn5xco-h2tbfQ6GBx6K5_oWRrPg33cH4_xPH-l9PdA75wFeBWJFnLlfE605lVShrpzZZLDOp-u6WFoVpZ1iGFipwT3gptvYm9y3XiS2kylJJl6hPs9x6sYBxPSeylk_TmTIcOWKNgmhCrOOfIjPL-IjW81sPNljLlUo7STXJ1O6kNm9v-o__ttzyGhwsazXY63D-BJVc9hQedseb1MyiOKM_wZLzTbLPhRZAYVctO3BmZldWzhtWekWmJdSU7ns4xcNaoHVr2tXUXbNdNp6wrx02oZboq2d7CR6btkPwcvt3J6F7AclVX7iUwcuiWMo6EyEtRpqlW2DEuBYSDjKwUA9jsZ6pYxIOm-DtNA3h304wrma5ndOXqefhGUkG3XA5gvUNDcdmVHCniHHktRt-Nf3f-FlYPTo9GxWg4PnwFa4i3rMsw34TldjZ3r-G-vWrPm9mbAFwGP-4aEn8Abyosxg
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLSAutOVRlhZqJDhaTRPbiZEQartdddUSrZaHekttx0aVtknZZEH9a_w6xnm0J7j1wNmRJcffjL8Zj-cDeGsVE56poqWFljITBVT7WlcZae1wIBeNWsO30zhNk7MzOV2B3_1bGF9W2fvExlHnpfE58t2mcRTSAS52XVcWMR2NP179oF5Byt-09nIaLURO7PUvDN-qD5MR7vW7MBwffTk8pp3CADUsSmoqtFOJSowQXHOn92ykIxmYPcW075tlLNKpwFrmDFPG6dBZqSKXc51gWJnHLsJ578FqjCSDDWD14Cidzm4yPD7dGjQSCqEIJUWeJPtr1ebtHh69vm4uphjIcSr-TnGbo2689j__pHV43BFsst9axAas2OIJPGglN6-fQvbJVyDO0v3qPZlcNsFHUZOZ_e5lzMpFRUpHvJyJsTmZzpfoUkuMKmryubaX5NDO56Rt1O3xTFSRk1GnMFO3GH8GX-9kdc9hUJSFfQHEa3dzHgaMyZzlcawEToxGghSbB4azIWz3u5Z1nqLKbrdsCG9uhtHG_cWNKmy5bL7hvtWb5EPYbJGRXbXNSLJQIuNFv_zy35PvwENEQnY6SU-24BFCL2lLz7dhUC-W9hXcNz_ri2rxukMxgfO7xsQfdPQ25g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNAs%3A+Important+Regulators+of+Induced+Pluripotent+Stem+Cell+Generation+and+Differentiation&rft.jtitle=Stem+cell+reviews+and+reports&rft.au=Zeng%2C+Zhao-Lin&rft.au=Lin%2C+Xiao-Long&rft.au=Tan%2C+Li-Lan&rft.au=Liu%2C+Ya-Mi&rft.date=2018-02-01&rft.eissn=2629-3277&rft.volume=14&rft.issue=1&rft.spage=71&rft_id=info:doi/10.1007%2Fs12015-017-9785-6&rft_id=info%3Apmid%2F29143183&rft.externalDocID=29143183
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2629-3269&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2629-3269&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2629-3269&client=summon